top_image
SCB-808 (依那西普 生物仿制药 水针剂型): 类风湿关节炎

SCB-808 is an etanercept biosimilar being developed as a ready-for-injection prefilled syringe formulation. All currently available etanercept biosimilars in China are approved as freeze-dried powder formulations.
.
Clover has successfully completed Phase I clinical testing; a Phase III clinical trial is planned to initiate in 2019.